Tetra Radar · Company Timeline

Denali Therapeutics Inc (DNLI)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved AVLAYAH to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II).

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.